Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 2, 2018
- Accepted for publication June 23, 2018
- Published online March 1, 2019.
Article Versions
- previous version (July 24, 2018 - 10:34).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.
Author Information
- Frederik L. Giesel1–3,
- Karina Knorr4,
- Fabian Spohn1,2,
- Leon Will1,
- Tobias Maurer5,
- Paul Flechsig1,
- Oliver Neels2,6,
- Kilian Schiller7,
- Horacio Amaral8,
- Wolfgang A. Weber4,
- Uwe Haberkorn1,3,
- Markus Schwaiger4,
- Clemens Kratochwil1,
- Peter Choyke9,
- Vasko Kramer8,
- Klaus Kopka2,6 and
- Matthias Eiber2,4
- 1Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
- 2German Cancer Consortium (DKTK), Heidelberg, Germany
- 3CCU Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 4Department of Nuclear Medicine, Technical University Munich, Munich, Germany
- 5Department of Urology, Technical University Munich, Munich, Germany
- 6Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 7Department of Radiation Oncology, Technical University Munich, Munich, Germany
- 8Center of Nuclear Medicine, PositronMed, FALP, Santiago, Chile; and
- 9Molecular Imaging Program, National Cancer Institute, Bethesda, Maryland
- For correspondence or reprints contact: Frederik L. Giesel, Department of Nuclear Medicine, Heidelberg University Hospital INF 400, 69120 Heidelberg, Germany. E-mail: frederik{at}egiesel.com
Cited By...
Article usage
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Jump to section
Related Articles
Cited By...
- 18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
- Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, 18F-rhPSMA-7, in Patients with Prostate Cancer
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
- Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
- Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values <= 0.5 ng/mL
- Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer
- Multimodality Imaging of Prostate Cancer
- The Future of Nuclear Medicine as an Independent Specialty